Weight Loss and Diabetes Drugs Linked to Pancreas Issues: Hundreds of Reports Surface
Health officials are investigating a potential link between weight loss and diabetes injections (GLP-1 medicines) and an increase in reports of acute pancreatitis. The Medicines and Healthcare products Regulatory Agency (MHRA) has received nearly 400 reports of acute pancreatitis associated with medications like Mounjaro, Wegovy, Ozempic, and liraglutide, with nearly half involving Mounjaro. Due to the severity of the disease and increased usage of these medicines, the MHRA is launching a study, including genetic testing, to explore potential factors. Both the MHRA and drug manufacturers emphasize the importance of reporting adverse events and the need for healthcare professionals to monitor patients closely.
John Q. Hosedrinker